University · Johor Bahru and Kuala Lumpur
Prima Nexus and Universiti Teknologi Malaysia (UTM)
Universiti Teknologi Malaysia (UTM) is a university in Johor Bahru and Kuala Lumpur. Prima Nexus has run or supported 4 workshops, seminars and events with UTM since 2017, covering ELISA, Multiplex immunoassay, Tissue engineering, Data analysis.
Highlights, newest first
Events and news with UTM, in pictures
Bengkel Pemodelan & Data Analisis
Prima Nexus and the Environmental Health Research Centre of the Institute for Medical Research (IMR) organised a five-day hands-on Modelling and Data Analysis Workshop (Bengkel Pemodelan & Data Analisis) at the NIH Complex, Setia Alam, from 19 to 23 August 2019.
See the event →
From skin cells to the MTT assay: Prima Nexus and cell culture workshops at four Malaysian universities in 2018
Prima Nexus co-organised cell culture workshops at Universiti Malaya, Sunway University and UPM in 2018, and supported a skin cell culture workshop at the Tissue Engineering Centre, UKM Medical Centre.
Read the story →
NOCERAL Orthopaedic Seminar and ELISA Workshop 2017
The National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Universiti Malaya, held its orthopaedic research seminar on 14 December 2017, followed on 15 December by an ELISA workshop co-organised by Prima Nexus.
See the event →The full record
Every event with UTM
4 events, newest first.
Case studies and news
Research and stories with UTM
- Prima Nexus worked with the Institute for Medical Research on data analysis and thalassemia workshops in 2019 (news, August 2019)
- From skin cells to the MTT assay: Prima Nexus and cell culture workshops at four Malaysian universities in 2018 (news, November 2018)
- Prima Nexus ELISA workshops at UPM, UiTM, Nuclear Malaysia, USM and Universiti Malaya, October to December 2017 (news, December 2017)
Work with us
Planning a workshop, a study or a lab set-up? Talk to us.
We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.